ESMO Video Pearls

Meeting Coverage

Atezolizumab outperforms chemo in poor-prognosis non-small cell lung cancer

Study is "a big call-out for us to fight for improved air quality," says Nicholas Rohs, MD

October 4, 2022

"Unfortunately, it's not a home run," says Roy Herbst, MD, PhD

September 27, 2022

It's "full speed ahead" for EGFR-positive patients, says Roy Herbst

September 20, 2022

But James Hu, MD, says he is encouraged that a randomized study was done for this rare tumor

October 14, 2021

Combination increased PFS as first-line treatment but has expected added toxicities

October 7, 2021

Edwin Choy briefly describes several abstracts that caught his attention

September 30, 2021

Bradley Monk, MD, details five potential FDA approvals on the horizon

October 14, 2020

New cohort adds bevacizumab to olaparib /durvalumab combo

October 7, 2020